Contact Us

What Are the Top ncRNA Sequencing Providers in China?

Choosing a provider for Ncrna Sequencing in China requires more than comparing quoted prices. Non-coding RNA studies may target small RNAs, long non-coding RNAs, or both, and each needs a suitable library strategy. FANTOM5, a consortium study published in Nature in 2014, profiled 975 human samples using cap analysis of gene expression. Its work illustrates how strongly RNA findings depend on sample selection and measurement methods. Results can vary. Even small protocol differences may affect transcript detection.

This guide compares Chinese providers by workflow transparency, sequencing options, quality controls, bioinformatics support, and project communication. The ENCODE Project Consortium’s 2020 Nature report catalogued more than 1.3 million candidate cis-regulatory elements, reflecting the scale and complexity of functional genomics data. That figure is not a measure of ncRNA provider performance. It does underline why careful interpretation matters. For practical comparisons, researchers should ask about RNA integrity thresholds, rRNA depletion or small-RNA enrichment, read depth, replicate design, and deliverable formats. Clear answers help. A low price alone says little about whether a service suits a specific tissue or research question. No single provider is best for every project. This comparison is a starting point, not a substitute for reviewing current protocols, sample requirements, and project-specific quotes.

What Are the Top ncRNA Sequencing Providers in China?
Table of Contents [Hide]
1 Defining ncRNAs: miRNAs are ~19–24 nt; lncRNAs exceed 200 nt
2 How to Compare Providers: Read Depth, Mapping Rate, and QC Metrics
3 Leading Chinese Providers: BGI Genomics, Novogene, OE Biotech, and Annoroad
4 Assessing Study Design: Biological Replicates and Small-RNA Read Depth
5 Evaluating Results: Differential Expression, FDR <0.05, and Data Security

Defining ncRNAs: miRNAs are ~19–24 nt; lncRNAs exceed 200 nt

Non-coding RNA (ncRNA) sequencing starts with a useful distinction: miRNAs are typically about 19–24 nucleotides long, while lncRNAs exceed 200 nucleotides. These size ranges are not just labels. They affect how RNA is extracted, enriched, and converted into a sequencing library. Short miRNAs can be missed when workflows favor longer fragments; lncRNA studies may need steps that reduce ribosomal RNA and preserve transcript coverage. Details matter.

When comparing sequencing providers in China, ask how each workflow handles both ends of this size spectrum. Request the library-preparation method, sample input limits, read configuration, and quality-control criteria. For miRNA projects, check whether adapter-ligation bias is assessed and small-RNA size selection is documented. For lncRNAs, ask how ribosomal RNA depletion, strand specificity, and transcript assembly are addressed. A sequencing report should show usable reads and mapping rates, not only raw totals. Sample type matters too; degraded tissue can distort apparent RNA profiles. Protocols may look comparable on paper yet detect different transcripts. No workflow is flawless. Compare pilot data when possible, and match the service to the biological question rather than choosing by price alone.

What Are the Top ncRNA Sequencing Providers in China?

ncRNA length benchmarks — a biological reference, not a provider ranking.

miRNAs are typically about 19–24 nucleotides (nt) long. lncRNAs are defined as longer than 200 nt, so 200 nt is shown as the threshold—not an upper limit. These benchmarks do not compare sequencing providers.

How to Compare Providers: Read Depth, Mapping Rate, and QC Metrics

When comparing ncRNA sequencing providers in China, ask for the usable read count after filtering, not just the number of reads generated. ENCODE RNA-seq data standards use roughly 30 million reads per replicate as a bulk gene-expression benchmark. That is a reference point, not a universal target for miRNA, lncRNA, or circRNA projects. Library type and research aim change the required depth. Ask providers to explain how they set it. More reads can help detect low-abundance transcripts, but they cannot fix poor RNA quality or biased library preparation.

Mapping rate needs context. Request the percentage mapped to the stated reference genome, plus uniquely mapped and multimapped fractions. For small RNAs, ask how adapter trimming and sequence-length filtering affect those figures. The SEQC/MAQC-III study tested four reference RNA samples across sequencing platforms and sites, underscoring the value of consistent processing and reproducibility checks (Nature Biotechnology, 2014). Compare replicate correlations, insert-size or read-length profiles, contamination checks, and RNA integrity data. Check the report itself. A single headline percentage is thin evidence. I would also ask for a sample-level QC table and criteria for reruns; these details are easy to overlook, and some pipelines still need closer review.

What Are the Top ncRNA Sequencing Providers in China? — How to Compare Providers: Read Depth, Mapping Rate, and QC Metrics

Provider-neutral comparison framework. No provider-specific performance data is presented; request project-matched reports and verify results before comparing providers.

Comparison dimension What to compare Evidence to request How to interpret it
Read depth Usable reads per sample after demultiplexing and filtering; compare only the same library type and sequencing configuration. Sample-level read counts, run configuration, filtering rules, and the stated definition of a usable read. There is no single read-depth target for all ncRNA projects. Requirements depend on RNA class, sample quality, study design, and analysis goals.
Mapping rate Percentage of retained reads aligning to the stated reference; ask whether the figure is unique, multi-mapped, or total alignment. Alignment report, reference genome and annotation versions, aligner and settings, and separate unique/multiple alignment counts. Rates are not directly comparable when references, filters, or definitions differ. Check whether the reference and annotation suit the organism and RNA class.
Raw-read quality Per-base quality scores, read length, adapter content, and the number of reads removed during filtering. Per-sample FASTQ QC reports and the filtering summary, including adapter and low-quality read handling. Review quality across all samples, not just a representative sample or a run-level average.
Library composition Read distribution across the ncRNA classes relevant to the study, such as miRNA, tRNA, snoRNA, and lncRNA. Annotated read-count tables, annotation source and version, and the treatment of multi-mapping reads. Composition depends on the library-preparation method and sample type; confirm that the workflow captures the RNA classes of interest.
Sample and library QC Input acceptance criteria, RNA integrity or quality assessment, library concentration, and fragment-size distribution where applicable. Documented acceptance criteria, per-sample measurements, and the provider’s policy for failed or borderline samples. Compare the same assay and measurement method; thresholds should be agreed for the sample type before submission.
Replicate consistency Between-replicate similarity using an explicitly stated metric and the same normalization approach. Sample-correlation matrix or equivalent analysis, with normalization and outlier-handling methods documented. Interpret in light of biological variation, batch design, and sample number; similarity alone does not establish data quality.
Reporting and reproducibility Completeness of deliverables and traceability of analysis steps. FASTQ files, QC reports, count tables, analysis scripts or software versions, reference details, and a clear data-delivery specification. Confirm deliverables, data-retention terms, and whether reanalysis is possible before placing an order.

Comparison note: Request the same sample type, library protocol, sequencing configuration, filtering definitions, and reference settings from each provider. Set project-specific acceptance criteria in advance rather than treating generic thresholds as universal performance guarantees.

Leading Chinese Providers: BGI Genomics, Novogene, OE Biotech, and Annoroad

China’s ncRNA sequencing market includes providers with different strengths, from large-scale sequencing capacity to focused RNA analysis. Their services may cover small RNA, long non-coding RNA, and circular RNA, but the exact panels and workflows vary. Ask which RNA classes are included, how libraries are prepared, and whether raw reads and analysis files are delivered. Details matter.

For a useful comparison, examine sample requirements and quality-control rules before requesting a quote. A provider should explain how it checks RNA integrity, removes unwanted ribosomal RNA when appropriate, and handles low-input material. Ask for example reports, too. Clear documentation helps teams review read depth, mapping rates, and differential-expression methods rather than relying on a polished summary. Not every sample behaves.

The strongest fit depends on the experiment, not just sequencing volume. A project focused on plant tissue may need different preparation from one using blood or cultured cells. Confirm replicate recommendations, turnaround estimates, data security practices, and support for follow-up questions. I would also ask how the analysis treats multiple testing and batch effects; these details are easy to overlook, even in a well-run project. A low price alone says little. Compare the proposed workflow with your study design, and record any assumptions before samples are shipped.

Assessing Study Design: Biological Replicates and Small-RNA Read Depth

What Are the Top ncRNA Sequencing Providers in China?

For a China-based ncRNA study, compare providers by study design, not advertised read totals. Small-RNA libraries can be affected by adapter ligation bias, RNA quality, and size selection. Ask how the lab checks insert-size profiles and filters low-quality reads. Request an example report showing mapping rates for miRNA, piRNA, and other small-RNA classes. More reads help. But usable reads matter more than raw totals.

Tips: Prioritize independent biological replicates over repeated sequencing of one sample. Balance treatment groups across extraction and library-preparation batches. Ask providers to explain their recommended read depth for your sample type and analysis goals. There is no single depth that fits every project.

Replicate number should reflect expected biological variation and the effect size you hope to detect. A small pilot can reveal whether the planned depth captures low-abundance targets. Still, pilot results may not represent every batch. That uncertainty deserves attention. Before choosing a provider, confirm that its quotation separates raw reads, quality-filtered reads, and mapped reads. Also check whether the analysis plan documents normalization and multiple-testing correction. Replicate planning can be less tidy than a spreadsheet suggests; sample limits sometimes force real trade-offs.

Evaluating Results: Differential Expression, FDR <0.05, and Data Security

What Are the Top ncRNA Sequencing Providers in China?
Evaluating Results: Differential Expression, FDR <0.05, and Data Security

When comparing ncRNA sequencing providers in China, look beyond platform names and headline read counts. Ask how samples are checked, libraries prepared, and low-quality reads filtered. For differential expression, request a clear analysis workflow, including normalization methods and the reference genome or transcript database used. Raw counts matter.

An FDR below 0.05 is a useful significance threshold, but it does not prove that a change is biologically important. Check adjusted p-values alongside fold changes, confidence, and replicate consistency. Ask whether batch effects and sample quality were assessed. A striking result can still be fragile. I would also question any report that hides filtering choices; small details can shift the candidate list.

Tips: Share a sample manifest and analysis plan before sequencing. Confirm who can access identifiable project files, where data are stored, how long they are retained, and how they are transferred. Request access controls and a deletion process in writing. Keep a local record of sample IDs and file checksums. One caveat: strong security language is not a substitute for verifiable procedures.

Article Source:

Ready to talk about water treatment?

Contact us

Please complete this form and we will be in touch